fbpx
Home Tags FDA

Tag: FDA

CT expecting 30,000 doses of J&J vaccine next week, pending FDA...

To date, Connecticut has vaccinated 73% of its population over the age of 75, and 44% of its population aged 65 to 74.

FDA issues warning to Whole Foods over misbranded items

The warning letter follows a series of recalls in the past year of more than 30 food products sold by Whole Foods.

NY likely to get first Covid-19 vaccines Dec. 15

New York state expects to receive its first batch of the Pfizer Covid-19 vaccine on Dec. 15 if approval for its use is granted...

Regeneron gets FDA approval for antibody cocktail to fight Covid-19

Tarrytown-based Regeneron has received an emergency use authorization from the U.S. Food and Drug Administration allowing use of its REGEN-COV2 antibody cocktail for the...

FDA authorizes new Covid-19 treatment

The U.S. Food and Drug Administration late Thursday afternoon issued an emergency use authorization to Eli Lilly and Co. to allow use of its...

Shelton’s NanoViricides moves forward with studies of possible Covid treatment

The company intends to perform certain core safety pharmacology studies to ensure safety of the drug candidate at Calvert Labs.

Cannabidiol products store opens in Mount Kisco

It’s not over-the-counter marijuana products that are being sold in a new store in Mount Kisco, although some people may think that’s the case. The...

Regeneron’s Ebola treatment granted FDA approval

Inmazeb is a mixture of three monoclonal antibodies and was designed to treat Zaire ebolavirus. It is the first FDA-approved treatment for Ebola virus infection in adult and pediatric patients.

Regeneron receives $450M federal contract for its potential coronavirus cocktail

Regeneron Pharmaceuticals has received a $450 million contract from the federal government to manufacture and supply REGN-COV2, its investigational treatment of COVID-19. The double antibody...

Westport’s BioSig gets FDA approval to move forward with potential COVID-19...

The trial will occur in hospitalized patients who have confirmed infection with SARS-CoV-2 and require supplemental oxygen.

Seeking a cure: Regeneron and NYMC in COVID-19 study

When a complex process that normally takes seven to nine months is accomplished in only eight days, you can be reasonably certain that something...

Rockland’s Chartwell Pharma says FDA delays cost it $1M

“It is incomprehensible,” the complaint states, that Woodfield “would have so little regard for Chartwell, as its customer, and … efforts at bringing the product to market.”

FDA fast-tracks Intensity Therapeutics’ breast cancer treatment

“Finding improved therapies for this disease is a critical unmet medical need,” said Lewis H. Bender, president and CEO of Intensity Therapeutics.

FDA clearance for Westport-based Lumendi’s surgical device

The product is a sterile, single-use, disposable, monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures.

CT shellfish industry, going strong, hopes for EU breakthrough

The FDA has begun the process of restoring U.S. shellfish producers’ access to European markets.